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Abstract
Background: Liver cancer is one of the main causes of cancer-related death in human. HOXA7 has been proved to
be related with several cancers.
Method: The expression levels of HOXA7 were examined by Western blot, qRT-PCR or ICH. MTT was used to detect
the proliferative rate of liver cancer cells. The invasive abilities were examined by matrigel and transwell assay. The
metastatic abilities of liver cancer cells were revealed in BALB/c nude mice.
Results: In this report, we revealed that HOXA7 promoted metastasis of HCC patients. First, increased levels of HOXA7
were examined in liver cancer especially in metastatic liver cancer. Moreover, higher expression level of HOXA7 was
associated with poorer prognosis of liver cancer patients. Overexpression of HOXA7 significantly enhanced proliferation,
migration, invasion in vitro and tumor growth and metastasis in vivo meanwhile silencing HOXA7 significantly inhibited
the aboves abilities of liver cancer cells. In this research, we identified that HOXA7 performed its oncogenic characteristics
through activating Snail.
Conclusion: Collectively, we identify the critical role and possible mechanism of HOXA7 in metastasis of liver cancer
which suggest that HOXA7 may be a potential therapeutic target of liver cancer patients.
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Background
Liver cancer is one of the leading causes of cancer-
related death all around the world [1, 2]. In recent years,
significant advances in diagnosis and treatment of liver
cancer are reported, but unfortunately, patients with
liver cancer still have a very dismal long-term prognosis.
In clinic, partial liver resection is the treatment of choice
for liver cancer patients [3]. However, intrahepatic recur-
rence and metastasis which simultaneously predict poor
outcome are the main challenges in the treatment of
patients with liver cancer. The identification of critical
biomarkers that suppress or promote these processes
may lead to novel therapeutic targets for improving the
prognosis of these patients.
As shown in reports, epithelial to mesenchymal transi-
tion (EMT), a phenomenon observed in developmental
program, is evoked during tumor invasion and metasta-
sis [4]. Researchers have discovered several molecular
pathways that mediate EMT in cancers [5–8]. EMT
could promote tumor cell invasion and metastasis as
well as lead to the generation of cancer stem cells with
increased self-renewal and tumor-initiating capabilities
and increased resistance to apoptosis and chemotherapy
[4, 9]. During EMT, dynamic changes in gene expression
and cytoskeletal re-organization are often discovered
[10]. One of the significant changes is loss of E-cadherin
which is essential for cell to cell adhesion, and suppres-
sion of E-cadherin is one of the key steps in EMT which
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not only disrupts cell to cell adhesions but also promotes
cellular invasion and metastasis [11].
Science researchers have revealed that EMT is closely
related with multiple regulatory networks containing
signaling pathways [12] and transcription factors [13].
Among them, Zinc finger protein Snail is mostly re-
ported to be associated with EMT and metastasis [14].
Snail, as a transcription factor, could bind to E-box se-
quences located in the promoter regions of target genes
activation of which could induce EMT and promote cell
invasion and metastasis [15].
In this study, we detected that the expression levels of
Snail and EMT markers were regulated by Homeobox pro-
tein A7 (HOXA7) which belong the HOX gene family.
Homeodomain-containing transcription factors encoded
by this gene were known to be key regulators of embryonic
development [16]. Moreover, HOXA7 has been reported
to be associated with progression of some tumors [17].
Here we explored the possible mechanism of EMT acti-
vated by HOXA7 in the metastasis of liver cancer.
Methods
Clinical samples and cell culture
Samples of liver cancer and their adjacent tissue samples
are obtained from the First Affiliated Hospital of Dalian
Medical University. For survival analysis, the essential
information of the liver cancer patients was collected
from the First Affiliated Hospital of Dalian Medical Uni-
versity. Parts of the samples are frozen in liquid nitrogen
for RNA or protein examination and the other parts are
fixed in paraformaldehyde for immunohistochemistry.
All cell lines are cultured in adaptive culture medium
according to ATCC and cultured at 37 °C in 5 % CO2.
Establishment of cell lines
Human gene HOXA7 was cloned into pBabe-puro vector
and shRNA of HOXA7 and Snail were cloned into pSuper-
puro vector. Retrovirus supernatants of containing pBabe,
pSuper, pBabe-HOXA7, pSuper-shHOXA7 #1, pSuper-
shHOXA7 #2 and pSuper-shSnail were produced in Phoe-
nix packaging cells. We respectively transfected indicated
cell lines with these different viral supernatant containing
4 μg/ml polybrene (Sigma). Then cells were selected by
puromycin (2 μg/ml).
RNA extraction, reverse transcription, and real-time
RT-PCR
Total RNA was extracted from freshly-frozen samples or
cells with TRIzol reagent (Invitrogen). Total RNA was
reverse-transcribed with First Strand cDNA Synthesis Kit
(Invitrogen). Real time PCR reactions were conducted using
Platinum SYBR Green qPCR SuperMix-UDG reagents
(Invitrogen) on the PRISM 7900HT system (Applied Bio-
systems). All reactions were done in triplicate and reactions
without reverse transcriptase were used as negative con-
trols. The GAPDH were used as the endogenous controls
and the 2-ΔΔCT equation was used to calculate the relative
expression levels.
Western blot analysis
Western blot analysis was conducted using anti-HOXA7,
anti-Snail, anti-E-cadherin, anti-N-cadherin, anti-α-catenin,
anti-vimentin and anti-β-actin. All antibodies were pur-
chased from Cell Signaling Technology.
Proliferation assay
MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl-tetrazolium
bromide, Solarbio, M8180) assay were used to detect
the proliferative rate of indicated cell lines. 1000 cells
were plated into 96-well plate and cultured at 37 °C.
MTT was dropped at 70 % density and the 96-well
plate was incubated for 4 h followed 150 μl DMSO
dropped after removing the supernatant carefully. The
OD values were measured by the machine (Multiskan 3)
at 0, 24, 48 and 72 h.
Transwell and matrigel assay
The effects of HOXA7 or Snail expression on cell migra-
tion and invasion were assessed using the wound-healing
and Transwell assays as previously described [18].
Immunohistochemical analysis
Following deparaffinization, liver cancer sections were
immunohistochemically analyzed using antibodies for
HOXA7, respectively, and subsequently were pathologi-
cally confirmed for the tumor phenotype and specific
immunostaining. The positive cells were counted under
a microscope and analyzed.
In vivo tumor growth model
Male BALB/c nude mice aged 4 to 6 weeks were pur-
chased from the Hunan Slac Jingda Laboratory Animal
Co., Ltd (Changsha, China). For tumor growth assay, in-
dicated cells were resuspended in PBS and 3 × 106 cells
(200 μl) were subcutaneously injected in the axilla of
nude mice. Six weeks later, mice were sacrificed, and tu-
mors were dissected and weighted. Animal handling and
research protocols were approved by the Animal Care
and Use Ethnic Committee.
In vivo metastasis
Male BALB/c nude mice aged 4 to 6 weeks were pur-
chased from the Hunan Slac Jingda Laboratory Animal
Co., Ltd (Changsha, China). For metastasis assay, cells
were resuspended in PBS at a concentration of 3 × 107
cells/ml. Cell suspension (0.1 ml) was injected into tail
veins of nude mice. All of the mice were killed by CO2
60 days after inoculation.
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Chromatin immunoprecipitation (ChIP)-qPCR
ChIP kit was purchased from Millipore and ChIP ex-
periments were carried out essentially as described
[19]. Immnuoprecipitated DNA was analyzed on the
ABI PRISM 7900HT sequence detection system. The
primers used for detection of promoters after ChIP are
available upon request.
Luciferase reporter assays
The cDNA encoding HOXA7 was subcloned into the ex-
pression vector pBabe and subcloning was confirmed with
sequencing by Shanghai Genechem Co., Ltd. The pGL3
reporter construct plasmid (−3000/+100) consisted of a
3100-bp genomic DNA fragment of the Snail promoter
(Promega, Madison, WI, USA). The pGL3-Snail promoter
plasmid or its negative control pGL3-basic plasmid carry-
ing the firefly luciferase reporter were co-transfected with
an internal control, pRL-TK Renilla vector (Promega), by
using Lipofectamine 2000 (Invitrogen). In addition, cells
were respectively transfected with 600 ng of HOXA7 over-
expression plasmid pBabe or its negative control pbabe-
vector. Cell lysates were harvested 48 h after transfection.
The firefly and renilla activities were measured by the
Dual-Luciferase Reporter Assay System (Promega). Firefly
luciferase activity was normalized to the Renilla luciferase
activity. Each transfection was repeated three times.
Statistical analysis
Statistical analysis Data were described as the mean ± SD.
Survival analysis was estimated using the Kaplan–Meier
method. The relationship between survival period and
each of the variables was analyzed using the log-rank test
for categorical variables. Comparisons between different
groups were undertaken using the Student two-tailed t
test. The criterion of statistical significance was P < 0.05.
Statistical analysis was done with SPSS/Win11.0 software
(SPSS Inc.).
Results
Ectopic levels of HOXA7 are related with metastasis and
prognosis of liver cancer
At the first time, we confirmed whether HOXA7 expres-
sion level was elevated in liver cancer by western blot.
As shown in Additional file 1: Figure S1A, the expres-
sion of HOXA7 was significantly increased in tumors.
Moreover, HOXA7 was overexpressed in 73.85 % liver
Fig. 1 The expression of HOXA7 is increased in metastatic liver cancer. a Quantification of HOXA7 in liver cancer samples. b Analysis of HOXA7
levels in non-metastatic and metastatic liver cancer tissues. Non-metastatic: cancer tissues without metastasis; metastatic: cancer tissues with
metastasis. c Western Blot analysis of HOXA7 levels in some liver cancer samples. P < 0.01 in panel b based on the Student t test. Error bars, SD.
The each number of replicates is 3
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cancer samples (48 samples of total 65 samples). Then
we analyzed the relationship between HOXA7 and me-
tastasis and found that both mRNA level (Fig. 1b) and
protein levels (Additional file 1: Figure S1B) of HOXA7
was significantly elevated in metastatic liver tumors. More-
over, the increased protein level of HOXA7 was confirmed
in 9 pairs of liver cancer samples (Fig. 1c). These results
above revealed that elevated level of HOXA7 was possibly
correlated with metastasis of liver cancer.
In order to further confirm the role of HOXA1 in liver
cancer, we identified HOXA7 expression level in tumor
samples. As shown in Fig. 2a, different expression levels of
HOXA7 were found in tumor sections by immunochemi-
cal stain. Quantificational analysis showed that positive
expression of HOXA7 was examined in 89 % tumor tis-
sues (Fig. 2b) while negative expression of HOXA7 was
examined in 88 % noncancerous tissues (Fig. 2c). Then we
confirmed whether HOXA7 was related with prognosis of
liver cancer patients, we carried out the bioinformatics
analysis of the dataset of liver cancer patients. As shown
in Fig. 2d, positive levels of HOXA7 were significantly
related with poorer survival of liver cancer patients
compared with those with negative HOXA7 expression
suggesting that HOXA7 was correlated with prognosis of
liver cancer patients.
HOXA7 accelerates liver cancer cell migration and
invasion
To better understand the role of HOXA7 in liver cancer,
we first examined HOXA7 levels in liver cancer cell lines
(Fig. 3a and b), then we used retroviral vectors to estab-
lish liver cancer cell lines stably overexpressing or silen-
cing HOXA7. The expression levels of HOXA7 in the
subsequent cell lines were examined by Western blotting
(Fig. 3c and e) and qRT-PCR (Fig. 3d and f). We next
examined the effects of HOXA7 on migration and inva-
sion of liver cancer cells. Transwell and matrigel assay
revealed that silencing HOXA7 significantly inhibited
MHCC97H (Fig. 4a and b) and HCCLM3 (Additional
file 2: Figure S2A and B) migrated or invaded through
the membrane to the bottom of the aperture while overex-
pression of HOXA7 promote these progresses in HeG2
(Fig. 4c and d) and HL-7702 (Additional file 3: Figure S3A
and B). These results revealed that HOXA7 promotes mi-
gration and invasion of liver cancer cells.
Fig. 2 HOXA7 is overexpressed and related to the prognosis of liver cancer patients. a Immunohistochemical analysis of HOXA7 levels in liver cancer
tissues and normal liver tissues. b Proportion analysis of HOXA7 levels in liver cancer tissues. c Proportion analysis of HOXA7 levels in normal liver
tissues. d Survival analysis of patients with liver cancers in an available dataset. The each number of replicates is 3
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HOXA7 acts oncogenic properties in vivo
To further confirm whether HOXA7 promote metastasis
in vivo, MHCC97H cell silencing HOXA7 or HepG2 cell
overexpressing HOXA7 were inoculated into tail vein of
BALB/C athymic mice respectively. Eight weeks later, we
observed that less mice injected with MHCC97H cell
silencing HOXA7 had distant metastasis (Fig. 5a). More-
over, less metastatic foci in lung (Fig. 5c and d) were
counted in each mouse injected with liver cancer cell silen-
cing HOXA7. On the contrary, overexpressing HOXA7
significantly increased the number of metastatic mice
(Fig. 5b) and metastatic foci in lung (Fig. 5e and f).
On the other hand, the effects of HOXA7 on cell pro-
liferation and tumor growth were examined by MTT
and tumor formation assay. As shown in Additional file
4: Figure S4A, silencing HOXA7 significantly inhibited
cell proliferation of liver cancer cells while overexpres-
sing HOXA7 promoted this progress (Additional file 4:
Figure S4B). Tests in vivo revealed that silencing HOXA7
significantly supressed tumor growth in vivo and in-
duced a decrease in tumor weights (Additional file 4:
Figure S4C). In contrast, overexpression of HOXA7
accelerated tumor growth and induced an increase in
tumor weights (Additional file 4: Figure S4D). Tests in
vivo revealed that HOXA7 could promote tumor
growth and metastasis of liver cancer.
Snail is essential for HOXA7-induced metastasis
HOXA7 was proved to be related with metastasis of liver
cancer above. To better understand the mechanisms by
which HOXA7 engaged in metastasis, we performed
gene expression profiling on MHCC97H-shHOXA7 and
Fig. 3 Examination of HOXA7 levels in established cell lines. a Western Blot analysis of HOXA7 levels in liver cancer cell lines. b qRT-PCR analysis of
HOXA7 levels in liver cancer cell lines. c Western Blot analysis of HOXA7 levels in MHCC97H and HCCLM3 cells silencing HOXA7. d qRT-PCR analysis of
HOXA7 levels in MHCC97H and HCCLM3 cells silencing HOXA7. e Western Blot analysis of HOXA7 levels in HepG2 and HL-7702 cells overexpressing
HOXA7. f qRT-PCR analysis of HOXA7 levels in HepG2 and HL-7702 cells overexpressing HOXA7. P < 0.01 in panel b, d and f based on the Student t test.
Error bars, SD. The each number of replicates is 3
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its control cells. Microarray analysis identified numbers
of genes significantly differentially expressed after silen-
cing HOXA7 (Fig. 6a) and Snail targets were the top
related genes (Fig. 6b). We next examined Snail expres-
sion levels in liver cancer cells overexpressing or silen-
cing HOXA7. As shown in Fig. 7a, decreased expression
levels of Snail were identified in liver cancer cells silen-
cing HOXA7 by western blot (Fig. 7a) and qRT-PCR
(Fig. 7b). In contrast, increased expression levels of Snail
were found in liver cancer cells overexpressing HOXA7
by western blot (Fig. 7c) and qRT-PCR (Fig. 7d). To
further confirm whether Snail was regulated by HOXA7,
we use linear correlation analysis to verify the relation-
ship between HOXA7 and Snail. As shown in Fig. 7e,
the expression levels of Snail were positively correlated
with the expression levels of HOXA7. Moreover, we
examined expression levels of Snail targets. As shown in
Additional file 5: Figure S5A, silencing HOXA7 signifi-
cantly increased epithelial cell markers (E-cadherin and α-
catenin) and decreased mesenchymal cell markers (N-cad-
herin and vimentin) while overexpression of HOXA7
showed the opposite effects (Additional file 5: Figure S5B).
The similar changes in EMT markers were confirmed by
qRT-PCR (Additional file 5: Figure S5C, D, E and F).
To study the mechanism by which HOXA7 activated
Snail, we performed quantitative chromatin immunopre-
cipitation (qChIP) assay in liver cancer cells with silence or
overexpression of HOXA7. We found that silencing
HOXA7 was associated with decreased Snail levels at re-
gion -2400-2150 in MHCC97H (Fig. 8b) and HCCLM3
(Fig. 8c). More occupancy of those Snail gene promoter re-
gions by HOXA7 was detected in HepG2-HOXA7 (Fig. 8d)
and KL-7702-HOXA7 (Fig. 8e). Moreover, in order to val-
idate the binding relationship between HOXA7 and the
promoter of Snail, we performed luciferase reporter asssay,
as shown in Additional file 6: Figure S6, HOXA7 signifi-
cantly increased the activity of Snail promoter. These re-
sults clearly indicated that HOXA7 induces transcriptional
activation of Snail by regulating promoter of Snail.
In order to confirm whether Snail was essential for
HOXA7-induced metastasis, we silenced Snail in liver
cancer cells with overexpression of HOXA7. Expression
levels of Snail were examined by western blot (Fig. 9a)
and qRT-PCR (Fig. 9b). We found that silencing Snail
significantly inhibited the numbers of cells migrated or
invaded through the membrane to the bottom of the
aperture of HepG2-HOXA7 cell (Fig. 9c) and KL-7702-
HOXA7 cell (Fig. 9d).
Fig. 4 HOXA7 promotes migration and invasion of liver cancer cells. a MHCC97H silencing HOXA7 possessed less migrating and invading abilities
in traswell and martigel assay. b The migrated or invaded cells silencing HOXA7 were plotted as the average number of cells in five random
fields. c HepG2 overexpressing HOXA7 possessed more migrating and invading abilities in traswell and martigel assay. d The migrated or invaded
cells overexpressing HOXA7 were plotted as the average number of cells in five random fields. P < 0.01 in panel b and d based on the Student t
test. Error bars, SD. The each number of replicates is 3
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Fig. 5 HOXA7 promotes metastasis of liver cancer. a The total numbers of mice with distant metastasis at 60 days after injection of MHCC97H
cells with silent expression of HOXA7 into tail vein. b The total numbers of mice with distant metastasis at 60 days after injection of HepG2 cells
with ectopic expression of HOXA7 into tail vein. c HE stain for metastatic foci in lung with injection of MHCC97H cell silencing HOXA7. d The number of
metastatic foci in lung with injection of MHCC97H cell silencing HOXA7. e HE stain for metastatic foci in lung with injection of HepG2 cell overexpressing
HOXA7. f The number of metastatic foci in lung with injection of HepG2 cell overexpressing HOXA7. P< 0.01 in panel d and f based on the Student t test.
Error bars, SD. The each number of replicates is 3
Fig. 6 HOXA7 is related with Snail. a Supervised hierarchical clustering of the genes differentially expressed after silent expression of PKM2. b Gene set
enrichment analysis was carried out using ConceptGen. Snail is the top related gene of HOXA7
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Collectively, HOXA7 activates Snail expression by
combining to the promoter of Snail. And increased tar-
get proteins of Snail promote the metastasis of liver
cancer. In a word, Snail is essential for the HOXA7-
induced metastasis.
Discussion
Homeobox genes were first identified in the fruit fly
Drosophila melanogaster [20]. 39 HOX genes locating
on different chromosomes numbered from 1 to 13 and
are organized into four clusters labeled A, B, C and D
[21]. In this study, we investigated the expression, func-
tion, and mechanisms of HOXA7 in liver cancer. We
found that HOXA7 expression is elevated in liver
cancer and higher level of HOXA7 is associated with
poorer prognosis of liver cancer patients. Liver cancer
cells with higher expression of HOXA7 were more ag-
gressive and mesenchynal. Overexpression of HOXA7
significantly promotes cell proliferation, migration and
invasion in vitro and tumor growth and metastasis in
vivo. Of note, we revealed that HOXA7 activates Snail
expression by combining to the promoter of Snail
which may be the mechanism of HOXA7-induced inva-
sion and metastasis (Fig. 9h).
The HOX family is critical for various aspects of dif-
ferentiation and morphogenesis both in the embryo and
in adult tissues [22]. Recently, an increasing number of
studies have indicated that HOX genes play important
Fig. 7 HOXA7 elevates expression level of Snail. a Western blot analysis of Snail in liver cancer cells with silencing HOXA7. b qRT-PCR analysis of Snail
in liver cancer cells with silencing HOXA7. c Western blot analysis of Snail in liver cancer cells with overexpression of HOXA7. d qRT-PCR analysis of Snail
in liver cancer cells with overexpression of HOXA7. e Linear correlation analysis between Snail and HOXA7. P < 0.01 in panel b and d based on the
Student t test. Error bars, SD. The each number of replicates is 3
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roles in oncogenesis [23–25]. Many cancers exhibit altered
HOX gene expression, particularly leukemia, breast, pros-
tate and lung carcinomas [26–30]. It has been reported that
HOXA7 stimulates human hepatocellular carcinoma prolif-
eration through cyclin E1/CDK2 [25]. However, the specific
functional role of HOXA7 in liver cancer remains unclear.
We here revealed that HOXA7 promotes metastasis of liver
cancer and the liver cancer patients with high HOXA7 level
have a dismal long-term prognosis. Moreover we revealed
the mechanism of HOXA7-induced metastasis correlated
with snail. These findings point out a novel regulatory
network of metastasis in liver cancer.
Metastasis is considered to be the main cause of
cancer-related death, and EMT is proved to be the key
step of metastasis [31, 32]. In reports, EMT can be in-
duced by transcription factor Snail [33] which is a re-
pressor of E-cadherin gene expression [15]. Moreover,
loss of E-cadherin has been considered to be one
Fig. 8 HOXA7 combines to the promoter of Snail. a Schematic presentation of two regions relative to the Snail transcriptional start site used
as primers to test HOXA7 occupied abundance. b and c qChIP was performed to assess HOXA7 occupancy in liver cancer cells with silent
expression of HOXA7. IgG was used as negative control. d and e qChIP was performed to assess HOXA7 occupancy in liver cancer cells with
overexpression of HOXA7. IgG was used as negative control. P < 0.01 in panel b-e based on the Student t test. Error bars, SD. The each number
of replicates is 3
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hallmark of EMT [34]. Snail, as the main regulatory of E-
cadherin, has been discussed in multiple papers. In this
study, we revealed a novel regulator of Snail. HOXA7 could
directly activate gene expression of Snail and induced EMT
in liver cancer cells which could improve the Snail-related
networks. HOXA7, as an upstream regulator of Snail, may
be a novel therapeutic and prognostic target of liver cancer.
Conclusions
In summary, high level of HOXA7 was related with
poorer prognosis of liver cancer patients. Overexpression
of HOXA7 significantly promoted invasion and metasta-
sis of liver cancer cells by activating Snail expression
suggesting that HOXA7 may be a novel therapeutic and
prognostic target of liver cancer.
Fig. 9 Snail is essential for HOXA-induced metastasis. a Western blot analysis of Snail in indicated cell lines. b qRT-PCR analysis of Snail in indicated cell
lines. c Transwell and matrigel assay of HepG2-HOXA7 cell with silent expression of Snail. d Transwell and matrigel assay of HL-7702-HOXA7 cell with
silent expression of Snail. e The total numbers of mice with distant metastasis at 60 days after injection of HepG2-HOXA7 cells with silent expression of
Snail into tail vein. f HE stain for metastatic foci in lung with injection of HepG2-HOXA7 cell with silent expression of Snail. g Numbers of metastatic foci
in lung with injection of HepG2-HOXA7 cell with silent expression of Snail. h Conclusion of regulatory mechanism of HOXA7 in this study. P < 0.01
based on the Student t test. Error bars, SD. The each number of replicates is 3
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Additional files
Additional file 1: Figure S1. Ectopic HOXA7 expression was related
with metastasis of liver cancer. (A) Analysis of HOXA7 levels in noncancerous
and tumorous tissues. (B) Analysis of HOXA7 levels in non-metastatic and
metastatic liver cancer tissues. P < 0.01 in panel A and B based on the Student
t test. Error bars, SD. The each number of replicates is 3. (JPG 976 kb)
Additional file 2: Figure S2. Silencing HOXA7 inhibits migration and
invasion of HCCLM3 cell. (A) HCCLM3 silencing HOXA7 possessed less
migrating and invading abilities in traswell and martigel assay. (B) The
migrated or invaded cells silencing HOXA7 were plotted as the average
number of cells in five random fields. P< 0.01 in panel B based on the
Student t test. Error bars, SD. The each number of replicates is 3. (JPG 1592 kb)
Additional file 3: Figure S3. Overexpression of HOXA7 promotes
migration and invasion of HL-7702 cell. (A) HL-7702 with overexpression of
HOXA7 possessed more migrating and invading abilities in traswell and
martigel assay. (B) The migrated or invaded cells overexpressing HOXA7
were plotted as the average number of cells in five random fields. P < 0.01
in panel B based on the Student t test. Error bars, SD. The each number of
replicates is 3. (JPG 1188 kb)
Additional file 4: Figure S4. HOXA7 promotes cell proliferation and
tumor growth of liver cancer cell. (A) MTT assay of liver cancer cells with
silent expression of HOXA7. (B) MTT assay of liver cancer cells with
overexpression of HOXA7. (C) Tumor formation assay of liver cancer cells
with silent expression of HOXA7. (D) Tumor formation assay of liver cancer
cells with overexpression of HOXA7. **P < 0.01 based on the Student t test.
Error bars, SD. The each number of replicates is 3. (JPG 3241 kb)
Additional file 5: Figure S5. HOXA7 promotes expression levels of EMT
markers. (A) Western blot analysis of EMT markers in liver cancer cells
with silent expression of HOXA7. (B) Western blot analysis of EMT markers
in liver cancer cells with overexpression of HOXA7. (C) qRT-PCR analysis
of EMT markers in liver cancer cells with silent expression of HOXA7. (D)
qRT-PCR analysis of EMT markers in liver cancer cells with overexpression
of HOXA7. P < 0.01 in panel C-F based on the Student t test. Error bars,
SD. The each number of replicates is 3. (JPG 4138 kb)
Additional file 6: Figure S6. Lucifease reporter assay show that HOXA7
significantly increases the activity of the prromoter of Snail. (JPG 266 kb)
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